Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 7/2012

01-07-2012 | Urologic Oncology

Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift

Authors: Maxine Sun, BSc, Firas Abdollah, MD, Marco Bianchi, MD, Quoc-Dien Trinh, MD, Claudio Jeldres, MD, Rodolphe Thuret, MD, Zhe Tian, BSc, Shahrokh F. Shariat, MD, Francesco Montorsi, MD, Paul Perrotte, MD, Pierre I. Karakiewicz, MD

Published in: Annals of Surgical Oncology | Issue 7/2012

Login to get access

Abstract

Background

Partial (PN) or radical nephrectomy (RN) represents the standard of care for patients with small renal masses. Active surveillance (AS) also may be considered. We examined the rates of PN, RN, and AS within a contemporary population-based cohort.

Methods

Using the surveillance, epidemiology and end results database, we identified 26,468 patients diagnosed with T1aN0M0 renal cell carcinoma, between years 1988 and 2008. Determinants of PN and AS were assessed using logistic regression analyses within surgically managed patients and within the entire cohort, respectively.

Results

Overall, 8,966 (34%), 14,705 (56%), and 2,797 (11%) patients underwent PN, RN, and AS, respectively. The rate of PN increased (4.7% in 1988 to 40.4% in 2008, P < 0.001), whereas the rate of RN decreased over time (92.9% in 1988 to 41.4% in 2008, P < 0.001). The rate of AS increased over time (2.4% in 1988 to 18.2% in 2008, P < 0.001). In multivariable analyses, the determinants for PN consisted of more contemporary year of diagnosis, younger patient age, male gender, Caucasian race, married status, and decreasing tumor size (all P ≤ 0.003). The determinants of AS consisted of more contemporary year of diagnosis, more advanced age, male gender, decreasing tumor size, and unmarried marital status (all P ≤ 0.001). Regional differences for management of localized RCC were detected.

Conclusions

It is encouraging that PN rates have increased in an eightfold fashion. Moreover, a fivefold increase was recorded for AS. These figures show a paradigm shift in the management of small renal masses.
Literature
1.
Lee C, Katz J, Shi W, Thaler H, Reuter V, Russo P. Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol. 2000;163:730–6.PubMedCrossRef
2.
Nguyen M, Gill I, Ellison L. The evolving presentation of renal carcinoma in the United States: trends from the surveillance, epidemiology and end results program. J Urol. 2006;176:2397–2400.PubMedCrossRef
3.
Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006;7:735.PubMedCrossRef
4.
Thompson RH, Leibovich BC, Lohse CM, Zincke H, Blute ML. Complications of contemporary open nephron sparing surgery: a single institution experience. J Urol. 2005;174:855.PubMedCrossRef
5.
Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors: is there a difference in mortality and cardiovascular outcomes? J Urol. 2009;181:55–61 (discussion 61–52).PubMedCrossRef
6.
Zini L, Perrotte P, Capitanio U, Jeldres C, Shariat SF, Antebi E, et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer. 2009;115:1465–71.PubMedCrossRef
7.
Campbell SC, Novick AC, Belldegrun A, Blute ML, Chow GK, Derweesh IH, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182:1271–9.PubMedCrossRef
8.
Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010;58:398–406.PubMedCrossRef
9.
Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, et al. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 2006;106:1276–85.PubMedCrossRef
10.
Dash A, Vickers A, Schachter L, Bach AM, Snyder ME, Russo P. Comparison of outcomes in elective partial vs. radical nephrectomy for clear cell renal cell carcinoma of 4–7 cm. BJU Int. 2006;97:939–45.PubMedCrossRef
11.
Patard JJ, Shvarts O, Lam JS, Pantuck AJ, Kim HL, Ficarra V, et al. Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol. 2004;171:2181–5.PubMedCrossRef
12.
Go A, Chertow G, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305.PubMedCrossRef
13.
Thompson RH, Kaag M, Vickers A, Kundu S, Bernstein M, Lowrance W, et al. Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol. 2009;181:993–7.PubMedCrossRef
14.
Zini L, Patard JJ, Capitanio U, Crepel M, de La Taille A, Tostain J, et al. The use of partial nephrectomy in European tertiary care centers. Eur J Surg Oncol. 2009;35:636–42.PubMedCrossRef
15.
Miller DC, Hollingsworth JM, Hafez KS, et al. Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol. 2006;175:853–7 (discussion 8).PubMedCrossRef
16.
Dulabon LM, Lowrance WT, Russo P, Huang WC. Trends in renal tumor surgery delivery within the United States. Cancer. 2010;116:2316–21.PubMed
17.
Sun M, Bianchi M, Trinh QD, Abdollah F, Schmitges J, Jeldres C, et al. Hospital volume is a determinant of postoperative complication, blood transfusion, length of stay after radical or partial nephrectomy. JURO. 2011;187(2):405–10.
18.
Volpe A, Jewett MAS. The natural history of small renal masses. Nat Clin Pract Urol. 2005;2:384–90.PubMedCrossRef
19.
Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008;112:1051–7.PubMedCrossRef
20.
Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J Urol. 2008;180:505–8 (discussion 508–9).PubMedCrossRef
21.
Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425–31.PubMedCrossRef
22.
American Urological Association. Guidelines for management of the clinical stage I renal mass. In: Diagnosis and treatment recommendations. American Urological Association Education and Research Inc.; 2009.
23.
Ljungberg B, Hanbury D, Kuczyk MA, et al. Guidelines on renal cell carcinoma. European Association of Urology; 2009:24–6.
24.
Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007;178:41–6.PubMedCrossRef
25.
Van Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, et al. A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol. 2007;51:1606–15.PubMedCrossRef
26.
Sun M, Thuret R, Abdollah F, Lughezzani G, Schmitges J, Tian Z, et al. Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis. Eur Urol. 2011;59(1):135–41.PubMedCrossRef
27.
Chow WH, Devesa SS, Warren JL, Fraumeni JF. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628–31.PubMedCrossRef
28.
Berndt SI, Carter HB, Schoenberg MP, Newschaffer CJ. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol. 2007;25:3589–95.PubMedCrossRef
29.
Stephenson A, Hakimi A, Snyder M, Russo P. Complications of radical and partial nephrectomy in a large contemporary cohort. J Urol. 2004;171:130–4.PubMedCrossRef
Metadata
Title
Treatment Management of Small Renal Masses in the 21st Century: A Paradigm Shift
Authors
Maxine Sun, BSc
Firas Abdollah, MD
Marco Bianchi, MD
Quoc-Dien Trinh, MD
Claudio Jeldres, MD
Rodolphe Thuret, MD
Zhe Tian, BSc
Shahrokh F. Shariat, MD
Francesco Montorsi, MD
Paul Perrotte, MD
Pierre I. Karakiewicz, MD
Publication date
01-07-2012
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 7/2012
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2247-0

Other articles of this Issue 7/2012

Annals of Surgical Oncology 7/2012 Go to the issue

Head and Neck Oncology

Risk Factors for Gastric-Tube Dependence Following Tongue Reconstruction

Endocrine Tumors

Sestamibi-Negative Patients: To Operate or Image?

Colorectal Cancer

Diagnostic Accuracy of MRI for Assessment of T Category, Lymph Node Metastases, and Circumferential Resection Margin Involvement in Patients with Rectal Cancer: A Systematic Review and Meta-analysis

Head and Neck Oncology

Clinical and Ultrasonographic Findings Affecting Nondiagnostic Results upon the Second Fine Needle Aspiration for Thyroid Nodules

Colorectal Cancer

Repeat Hepatectomy for Metastatic Colorectal Cancer Is Safe but Marginally Effective

Pancreatic Tumors

Adjuvant PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) or Gemcitabine Followed by Chemoradiation in Pancreatic Cancer: A Randomized Phase II Trial